H-015

N/A

Report date: 2022/12/27 17:24:22
NME

Base Information

Drug NameH-015
Drug Alias NameH-015
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPolymerase acidic protein inhibitors
TargetsPolymerase acidic protein
Therapy Area/IndicationsInfluenza, Human
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesJiangsu Carephar Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesJiangsu Carephar Pharmaceutical Co Ltd
Inactive CompaniesN/A
Active IndicationsInfluenza, Human
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A